State Street
TCRT icon

State Street’s Alaunos Therapeutics TCRT Stock Holding History

State Street’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,021
Closed -$35.1K – 4337
2024
Q2 		$35.1K Sell
5,021
-12
-0.2% -$143 ﹤0.01% 4207
2024
Q1 		$91.1K Sell
5,033
-1
-0% -$20 ﹤0.01% 4046
2023
Q4 		$53.4K Sell
5,034
-18
-0.4% -$217 ﹤0.01% 4186
2023
Q3 		$99.9K Hold
5,052
– – ﹤0.01% 4117
2023
Q2 		$386K Sell
5,052
-162
-3% -$13.1K ﹤0.01% 3757
2023
Q1 		$493K Hold
5,214
– – ﹤0.01% 3750
2022
Q4 		$508K Sell
5,214
-15,975
-75% -$2.32M ﹤0.01% 3769
2022
Q3 		$5.47M Buy
21,189
+15,435
+268% +$4.48M ﹤0.01% 3012
2022
Q2 		$1.07M Sell
5,754
-29,015
-83% -$2.77M ﹤0.01% 3617
2022
Q1 		$3.4M Sell
34,769
-54,023
-61% -$6.93M ﹤0.01% 3355
2021
Q4 		$14.5M Buy
88,792
+10,952
+14% +$2.41M ﹤0.01% 2686
2021
Q3 		$21.3M Buy
77,840
+5,442
+8% +$1.66M ﹤0.01% 2448
2021
Q2 		$28.7M Sell
72,398
-8,944
-11% -$4.17M ﹤0.01% 2270
2021
Q1 		$43.9M Buy
81,342
+22,910
+39% +$14.3M ﹤0.01% 1830
2020
Q4 		$22.1M Sell
58,432
-4,479
-7% -$1.78M ﹤0.01% 2187
2020
Q3 		$23.8M Buy
62,911
+9,181
+17% +$4.06M ﹤0.01% 1922
2020
Q2 		$26.4M Buy
53,730
+11,074
+26% +$4.94M ﹤0.01% 1873
2020
Q1 		$15.7M Buy
42,656
+3,072
+8% +$1.59M ﹤0.01% 1999
2019
Q4 		$28M Sell
39,584
-7,792
-16% -$5.36M ﹤0.01% 1902
2019
Q3 		$30.4M Buy
47,376
+10,457
+28% +$8.3M ﹤0.01% 1777
2019
Q2 		$32.3M Buy
36,919
+899
+2% +$618K ﹤0.01% 1771
2019
Q1 		$20.8M Buy
36,020
+2,480
+7% +$1.04M ﹤0.01% 2015
2018
Q4 		$9.41M Sell
33,540
-3,696
-10% -$1.46M ﹤0.01% 2468
2018
Q3 		$17.9M Buy
37,236
+3,976
+12% +$1.7M ﹤0.01% 2252
2018
Q2 		$15.1M Sell
33,260
-11,123
-25% -$7.05M ﹤0.01% 2327
2018
Q1 		$26.1M Buy
44,383
+5,566
+14% +$3.47M ﹤0.01% 1870
2017
Q4 		$24.1M Buy
38,817
+9,240
+31% +$6.64M ﹤0.01% 1922
2017
Q3 		$27.2M Sell
29,577
-798
-3% -$709K ﹤0.01% 1802
2017
Q2 		$28.3M Buy
30,375
+3,447
+13% +$3.38M ﹤0.01% 1739
2017
Q1 		$25.6M Buy
26,928
+152
+0.6% +$142K ﹤0.01% 1760
2016
Q4 		$21.5M Sell
26,776
-5,127
-16% -$4.62M ﹤0.01% 1845
2016
Q3 		$26.9M Buy
31,903
+880
+3% +$707K ﹤0.01% 1568
2016
Q2 		$25.5M Buy
31,023
+2,682
+9% +$2.92M ﹤0.01% 1581
2016
Q1 		$31.5M Sell
28,341
-5,966
-17% -$6.11M ﹤0.01% 1418
2015
Q4 		$42.8M Buy
34,307
+6,389
+23% +$10.6M ﹤0.01% 1252
2015
Q3 		$37.7M Sell
27,918
-1,769
-6% -$2.92M ﹤0.01% 1328
2015
Q2 		$53.4M Buy
29,687
+8,628
+41% +$13.4M 0.01% 1225
2015
Q1 		$34M Sell
21,059
-1,239
-6% -$1.84M ﹤0.01% 1461
2014
Q4 		$17M Buy
22,298
+666
+3% +$354K ﹤0.01% 1911
2014
Q3 		$8.56M Sell
21,632
-3,389
-14% -$1.63M ﹤0.01% 2267
2014
Q2 		$15.1M Sell
25,021
-3,030
-11% -$1.69M ﹤0.01% 1997
2014
Q1 		$19.3M Buy
28,051
+5,515
+24% +$3.69M ﹤0.01% 1814
2013
Q4 		$14.7M Buy
22,536
+15,417
+217% +$9.18M ﹤0.01% 1961
2013
Q3 		$4.22M Sell
7,119
-18
-0.3% -$8.11K ﹤0.01% 2629
2013
Q2 		$2.25M Buy
+7,137
New +$1.98M ﹤0.01% 2919

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SWM
Sugarloaf Wealth Management Duluth, Georgia $529M AUM 14.14% 1-Year Est. Return

State Street's TCRT Position: Q3 2024 in Review

State Street sold out of Alaunos Therapeutics (TCRT) in Q3 2024, closing a stake of 5,021 shares — an estimated $35.1K sold.

State Street first reported a position in TCRT in Q2 2013 and held it in 45 quarters. The position peaked at $53.4M in Q2 2015. 29 funds tracked by Wall St. Rank hold TCRT as of Q3 2024.

  • State Street reported no remaining Alaunos Therapeutics position as of Q3 2024 after selling out during the quarter.
  • State Street sold 5,021 Alaunos Therapeutics shares in Q3 2024, an estimated $35.1K.
  • State Street first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 45 quarters.
  • State Street's Alaunos Therapeutics position peaked at $53.4M in Q2 2015.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2024.

Based on State Street's 13F filing for Q3 2024, filed 14 Nov 2024.